Gosset Alpha-hemolysin Overview
Alpha-hemolysin is a pore-forming toxin produced by the bacterium *Staphylococcus aureus*. It is synthesized as a 293-residue, water-soluble monomer that binds to susceptible cell membranes, where seven monomers assemble into a heptameric beta-barrel pore. This pore formation disrupts cellular membrane integrity, causing leakage of ions and metabolites, resulting in cell death via either apoptosis or necrosis depending on concentration. Alpha-hemolysin plays a central role in the pathogenesis of S. aureus infections by lysing host cells (including erythrocytes and immune cells), contributing to tissue destruction, immune evasion, and disease severity. It is also widely used as a biotechnological nanopore tool in single-molecule sequencing research[1][2][4][5][7][8].
Mechanism of Action
Binding to host cell membranes (specific receptor not fully identified) Oligomerization (usually as a heptamer) to form a transmembrane beta-barrel pore Pore formation results in uncontrolled ion flux, cell lysis, apoptosis (at low concentrations), and necrosis (at high concentrations)[1][2][4][5][8].
Biological Functions
Disease Associations
Safety Considerations
- Potent cytotoxicity limits direct therapeutic use
- Broad activity may damage host tissues, leading to safety challenges for inhibitors (unintended immune modulation, off-target effects)
- Potential immunogenicity in anti-toxin strategies[5]
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| Presence of anti-alpha-hemolysin antibodies may indicate exposure to Staphylococcus aureus[5] |
| Alpha-hemolysin gene (hla) as marker for virulent S. aureus strains |